Financhill
Back

Entero Therapeutics Quote, Financials, Valuation and Earnings

The Next Nvidia?

Go here now for this breaking story.
Sell
4

ENTO
Entero Therapeutics

Last Price:
1.76
Seasonality Move:
-38.08%

7 Day Trial

ALL ACCESS PASS

$ 7

This New Idea is Set to Shock the World

Click here to learn all the details.

Entero Therapeutics Price Quote

$1.76
-0.04 (-0.65%)
(Updated: June 26, 2024 at 5:05 AM ET)

Entero Therapeutics Key Stats

Sell
4
Entero Therapeutics (ENTO) is a Sell

Day range:
$1.73 - $1.91
52-week range:
$1.70 - $33.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.32%

Volume:
47.1K
Avg. volume:
29.7K
1-year change:
-94.51%
Market cap:
$5.1M
Revenue:
$0
EPS:
$-49.3

How Much Does Entero Therapeutics Make?

Data Unavailable

Is Entero Therapeutics Growing As A Company?

Data Unavailable

Entero Therapeutics Stock Price Performance

What Is Entero Therapeutics 52-Week High & Low?

Entero Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Entero Therapeutics?

Is Entero Therapeutics Cash Flow Positive?

  • What Is ENTO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$13.3M
  • What Is Entero Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $15.1M
  • What Is Entero Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Entero Therapeutics Return On Invested Capital

Data Unavailable

Entero Therapeutics Earnings Date & Stock Price

Entero Therapeutics Competitors

Entero Therapeutics Dividend Yield

Data Unavailable

Entero Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -1008.06%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 36.00
Upside from Last Price: 1900%

Major Shareholders

  • How many ENTO shares are owned by institutional investors?
    51K ENTO shares are owned by institutional investors
  • How many ENTO shares are owned by insiders?
    735.3K ENTO shares are owned by insiders